What Brands can learn from the AstraZeneca disaster on fighting fake news

Published by

It would be hard to define the AstraZeneca rollout anything other than a small disaster.

The pharmaceutical company that was deemed the saviour from the all-mighty Covid blight is now going through a substantial PR crisis, with fake news popping up here and there, and even vaccine doses and passports being sold on the Dark Web. It is a mess.

And it all started from a series of fake news in Italy, a bandwagon on which media were quite eager to jump straight away.


The Italian case

It happened that a teacher in Piedmont received a jab for the AZ vaccine just around 10 days ago. The woman died shortly after, leading to widespread panic in the nation about whether AstraZeneca was safe or not, and similar pieces of news (with fake correlations and assumptions) being released everywhere.

Little did it matter that the WHO and AstraZeneca themselves have stated that there is no known correlation between the vaccine and blood clots. Once the news was out in the open, vaccine rollout was halted across many European countries, and more and more news or questions started popping up about AstraZeneca.

Fake news on AstraZeneca are just the tip of the iceberg of a disastrous campaign.

It was pretty much the lowest point ever reached by the Anglo-Swedish manufacturer after admittedly a disastrous campaign on the vaccines themselves. Right there in Italy, AstraZeneca was also accused of stockpiling vaccine doses instead of distributing them – in a country which has experienced shortage of vaccines the very week they were released. Again, little did it matter that the stock was already destined to Europe – people were already believing that the company had been hiding them away from citizens, for some very unclear reason.

Outside of Italy and shortly after the fact, the US has also questioned the efficacy of the vaccine by claiming that the data used to determine its success rate was obsolete.

If that is not a disastrous rollout, I don’t know what is.


KFC is a master in handling PR crises. We talked about this and more incredible campaigns in our article on crisis management.

How did the company react to these false allegations?

Once trust in your actions has been undermined, it’s pretty difficult to clean your reputation in the eyes of the public. AstraZeneca did what any other brand would have done: they denied that any of those voices were true. But panic had already spread, and no matter what the company may say now, people are increasingly wary of this vaccine and its actual safety.

There is no denying that the AstraZeneca brand was handled quite poorly in this regard. Science is already quite difficult to communicate to the general public, and AstraZeneca did no real effort to make things easier in such an unprecedented situation. You would think that denying all false allegations is enough, but you can easily see why that may not be necessarily true. People in Italy are still panicking, and the fake news train has departed now. Those wanting to undermine the credibility of AstraZeneca have all the power to do so, by leveraging what the public ignores to build their own narrative.

In this matter and context, you can argue that AstraZeneca lacked transparency. The best way for the company to protect itself was to avoid relying on middlemen and media, reaching out personally to the public as a pharmaceutical brand, perhaps through an awareness campaign or a specific awareness partnership with the government.

Of course we know that the public isn’t particularly receptive when it comes to the language of science. Alas, we will never know if this case would have been different.


Image credit: Birger Linke

What Brands can learn from the AstraZeneca response

Clearly AstraZeneca is a manufacturer, not necessarily a brand in the most literal sense (though they do list purpose, values and such and such). Still, this story shows the importance of building, nurturing and developing a brand. It doesn’t matter that the company helped with hundreds of thousands of Covid-19 tests last year, nor that it distributed an even larger number of face masks in early 2020 – that reputation was not maintained, and the public was wary of a random pharmaceutical giant stepping up as the saviour of us all. Especially in this age, when conspiracy theories and fake news are more widespread than ever.

We now know the consequences of that.

It’s hard to imagine that AstraZeneca didn’t see this coming, but to an extent, we can say that’s exactly the case. With growing concerns about the safety and efficiency of the vaccine rollout programmes, AstraZeneca sat back and focused on distribution, expecting the public to just buy into whatever narrative they were (not) selling.

The best way to defend your brand against fake news is by monitoring your online presence constantly

The best way to defend your brand against fake news is by monitoring your online presence constantly, especially if you’re such a public company. Somewhat cynically, I know for a fact there will be people out there who have been waiting for such an event to spark doubt in the general public. Brands should spot trends as they rise and address those concerns before it becomes too late. Fake news and concerns on the presumed dangers of AstraZeneca have been going around for a while, but it wasn’t until someone died that the company issued a public statement. And not even a much effective one at that.

With consumer trust decreasing at record rates as soon as a PR crisis is in place, brands should always aim for transparency and honesty, focusing on their brand value and being ready to appoint a response team to spread awareness in the public if needed. Now take a look at AstraZeneca’s Twitter page and try to spot anyone replying to the community’s comments. No one? Didn’t think so.

It might be a stretch to say that the AstraZeneca vaccine rollout is a disaster because of their poor brand reputation. Though it certainly appears that their poor brand reputation had a huge part to play in that, which is a shame, considering the impressive and absolutely incredible job they have done to produce vaccines in under a year.

I have zero doubts that the AstraZeneca vaccines are safe. Sadly, people like me seem to be decreasing in numbers by the day.

And guess who we will blame, when a 4th lockdown comes knocking at our doors?

Header image: Adriano Elias


More Features



Working smarter, not harder: Top tips for freelance creators

Freelancers and independent contractors have a lot to keep track of. Whether you tend to take on lots of fast turnaround jobs or spend months at a time with one single client, it’s likely you have an abundance of files and admin that go along...

Posted by: Creativepool Editorial


Hospitality and the Metaverse | #PurposeMonth

For the last twelve years, Matter Of Form have had the privilege to deliver exceptional brand and digital experiences to some of the very best luxury brands in the global travel and hospitality sector. And we have got to know the dedicated tribe who...

Posted by: Matter Of Form


Which 5 design trends are most useful for marketing in summer 2022?

It is never too late to include design into your marketing plan, especially in the context of a new season. Here are five of the most promising design ideas for summer 2022 (with examples) to assist your organisation in meeting and crushing its...

Posted by: Chris Bicourt
ad: Annual 2022 Final Deadline